Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-04

Clinical Trial Update: Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes [NA]

View source ↗

Summary

The clinical trial evaluating glycated albumin as an intervention to improve glycemic control in Chinese patients with Type 2 Diabetes has completed, and result…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glycated albumin intervention

Snippet

Sponsor: Asahi Kasei Therapeutics Corporation | Conditions: Type 2 Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2025-12-04